Gadoquatrane showed pediatric safety and pharmacokinetic profiles similar to adults in a study, supporting use as a low-dose ...
HealthDay on MSN
Medical imaging contributing to water pollution, experts say
Key Takeaways Medical imaging contrast agents are contributing to water pollutionMedicare patients alone received 13.5 ...
Bayer, a global leader in radiology, today revealed results from the QUANTI Pediatric study, adding to the pharmacokinetic, safety and efficacy data of the investigational low-dose MRI ...
Bayer revealed first results of the pediatric study from the pivotal clinical development program QUANTI for its low-dose MRI contrast agent QUANTI Pediatric evaluated the pharmacokinetics and safety ...
A comprehensive study by the CritMET research group, led by Prof. Michael Bau, a geochemist at Constructor University in Bremen, provides evidence of widespread contamination of the North Sea and the ...
CORVALLIS, Ore. (KTVZ) -– Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents ...
Scientists have developed a new class of MRI contrast agents that are both more stable and 30 percent more effective than previous designs. Researchers at the University of Birmingham have announced a ...
Scientists at Oregon State University (OSU) have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents while being less toxic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback